Etiology, pathology and therapy of renal cell carcinoma;Atiologie, pathogenese und therapie des nierenzellkarzinoms

Radiologe

Volumn 39, Issue 5, 1999, Pages 343-349

  Fischer, C G ^a,b  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Carcinoma, renal cell; Cell transformation; Immunotherapy; Surgical procedures

Indexed keywords

ARTICLE; CARCINOGENESIS; CELL TRANSFORMATION; DIALYSIS; GENE MUTATION; HISTOPATHOLOGY; HUMAN; IMMUNOTHERAPY; KIDNEY CARCINOMA; OBESITY; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SMOKING;

ADJUVANTS, IMMUNOLOGIC; ADULT; CARCINOMA, RENAL CELL; CYTOGENETICS; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOTHERAPY; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; NEPHRECTOMY; ONCOGENES;

EID: 0033019891     PISSN: 0033832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001170050521     Document Type: Article

References (28)

1. Benhamou S, LenfantMH,Ory-PaolettiC, Flamant R (1993) Risk factors for renal-cell carcinoma in a french case-control study. Int J Cancer 55:32-36
2. Birchmeier W, Weidner K, Hülsken J, Behrens J (1993) Molecular mechanisms leading to cell junction (cadherin) deficiency in invasive carcinomas. Semin Cancer Biol 4:231-239
3. Chow WH, McLaughlin JK, Mandel JS, Wacholder S, Niwa S, Fraumeni F (1996) Obesity and risk of renal cell cancer. Cancer Epidemiol Biomarkers Prev 5:17-21
4. Delahunt B, Bethwaite PB, Thornton A (1997) Prognostic significance of microscopic vascularity for clear cell renal cell carcinoma. Br J Uro 80:401-404
5. Elfving P, Mandahl N, Lundgren R, Limon J, Bak Jensen E, Ferno M, Olsson H, Mitelman F (1997) Prognostic implications of cytogenetic findings in kidney cancer. Br J Urol 80:698-706
6. Fischer C, Waechter W, Kraus S, Perez FF, Weidner W, Dudeck J (1998) Urologic tumors in the Federal Republic of Germany - Data on 56,013 cases from Hospital Cancer Registries. Cancer 82:775-783
7. Gilcrease MZ, Truong L, Brown RW (1996) Correlation of very late activation integrin and CD44 expression with extra renal invasion and metastasis of renal cell carcinomas. Hum Pathol 27:1355-1360
8. Gill IS, McClennan BL, Kerbl K, Carbone JM, Wick M, Clayman RV (1994) Adrenal involvement from renal cell carcinoma: predictive value of computerized tomograpy. J Urol 152:1082-1085
9. Günthert U, Hofmann M, Rudy W, Reber S, Zöller M, Haubmann I, Martzku S, Wenzel A, Ponta H, Herrlich P (1991) A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65:3-24
10. Hall PA, Woods AL (1990) Immunohistochemical markers of cell proliferation. Achievements, problems and prospects. Cell Tissue Kinet 23:531-549
11. Hänninen EL, Kirchner H, Atzpodien J (1996) Interleukin-2 based home therapy of metastatic renal cell carcinoma, risks and benefits in 215 consecutive single institution patients. J Urol 155:19-25
12. Huland E, Heinzer H, Mir Th S, Huland H (1997) Inhaled interleukin-2 therapy in pulmonary metastatic renal cell carcinoma: six years of experience. Cancer J Sci Am 3:98-195
13. Kohler HH, Barth PJ, Siebel A, Gerharz EW, Bittinger A (1996) Quantitative assessment of vascular surface density in renal cell carcinomas. Br J Urol 77:650-654
14. Kovacs G (1994) The value of molecular genetic analysis in the diagnosis and prognosis of renal cell tumors. World J Urol 12:64-68
15. MacLennan GT, Bostwick DG (1995) Microvessel density in renal cell carcinoma: lack of prognostic significance. Urology 46:27-30
16. Mareel M, Vleminckx K, Vermeulen S, Bracke M, Van Roy F (1992) E-cadherin expressions counterbalance for cancer cell invasion. Bull Cancer 79:347-355
17. Mickisch GH, Roehrich K, Koessig J, Forster St, Tschada RK, Alken PM (1990) Mechanisms and modulation of multidrug resistance in primary human renal cell carcinoma. J Urol 144:755-759
18. Modi H, Schraml P, Bubendorf L, Richter J, Gasser TC, Mihatsch MJ, Sauter G (1998) Intratumoral heterogeneity of von Nippel-Lindau gene deletions in renal cell carcinoma detected by fluorescence in situ hybridization. Cancer Res 58:2304-2309
19. Morton RA Jr, Ewing CM, Watkins JJ, Isaacs WB (1995) The E-cadherin cell-cell adhesion pathway in urologic malignancies. World J Urol 13:364-368
20. Muscat JE, Hoffmann D, Wynder EL (1995) The epidemiology of renal cell carcinom. Cancer 75:2552-2557
21. Negrier S, Escudier B, Lasset C, Douillard JY, Savary J, Chevrea u C, Ravaud A, Mercatello A, Peny J, Mousseau M, Philip T, Tursz T (1998) Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. N Engl J Med 338:1272-1278
22. Oberneder R, Kriegmair M, Staehler M, Hofstetter A (1997) Immuntherapie des metastasierten Nierenzellkarzinoms. Urologe [A] 36:130-137
23. Robson CJ, Churchill BM, Anderson W (1969) The results of radical nephrectomy for renal cell carcinoma. J Urol 101:297-301
24. Shameem IA, Shimabukuro T, Wada T, Kurisu H, Naito K (1996) Expression of proliferating cell nuclear antigen and deoxyribonucleic acid value in renal cell carcinoma: correlation with different histopathological parameters and patient survival. Eur Urol 29:78-84
25. Staehler G, Brkovic D (1997) Nierenzellkarzinome mit V.-cava-Befall. Urologe [A] 36:109-116
26. Tanioka F, Hiroi M, Yamane T, Hara H (1993) Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma. Zentralbl Pathol 139:185-193
27. Terpe HJ, Zimmer U, Fischer C, Störkel S (1995) Distribution and role of adhesion molecules in renal tumors. J Urol Pathol 3:37-49
28. Thoenes W, Störkel S, Rumpelt HJ (1986) Histopathology and classification of renal tumours (adenomas, oncocytomas and carcinomas): the basic cytological and histopathological elements and their use for diagnostics. Pathol Res Pract 181:125-143